Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Cumberland Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01118663
First received: May 4, 2010
Last updated: June 21, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2013
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)